|
|
||||||||
a Division of Cardiovascular Surgery, Department of Surgery, Taipei Veterans General Hospital, Taipei, Taiwan
b National Yang-Ming University, Institute of Clinical Medicine, School of Medicine, Taipei, Taiwan
c Division of Cardiology, Department of Internal Medicine, Taipei Medical University Hospital, Taipei, Taiwan
Accepted for publication June 9, 2008.
* Address correspondence to Dr Shih, Department of Cardiovascular Surgery, Taipei-Veterans General Hospital, No. 201, Sec 2, Shi-Pai Rd, Taipei, 112, Taiwan (ROC) (Email: ccshih{at}vghtpe.gov.tw).
Background: Left ventricular aneurysm repair (LVAR) prevents congestive heart failure after myocardial infarction (MI). LV dilation after MI is related to postinfarct myocardial remodeling and leads to CHF. Because changes in matrix metalloproteinases (MMPs), tissue inhibitors of metalloproteinases (TIMPs), and the physical properties of collagens are involved in myocardial remodeling, the effect of postinfarct LVAR on these factors was tested.
Methods: Rats with surgically induced MI, which did or did not receive postinfarct LVAR, were compared with each other and with controls. TIMP messenger RNA and protein expression, MMP gelatin zymography activity, and collagen fibrosis were measured in heart tissue.
Results: A threefold difference in the infarction area ratio was observed between samples of LVAs and of repaired LVAs. Compared with rats without LVAR, rats with repaired LVAs exhibited a higher percentage fractional shortening and significantly lower LV end-systolic and end-diastolic diameters. These salutary effects on LV diameter after LVAR were accompanied by a reversal of myocardial remodeling activity. After MI, TIMP expression decreased, MMP activity increased, and collagen fibrosis increased. After LVAR, TIMP expression increased, and MMP activity and collagen fibrosis decreased. These markers of remodeling activity changed significantly and approached preinfarct levels after LVAR.
Conclusions: This study demonstrated that postinfarct LVAR prevents further congestive heart failure by attenuating myocardial remodeling in the LV and is thus indicated both to prevent heart failure and to reduce excessive postinfarct myocardial remodeling.
Related Article
Ann. Thorac. Surg. 2008 86: 1249.
This article has been cited by other articles:
![]() |
C. Zhang, J. Hou, S. Zheng, Z. Zheng, and S. Hu Vascularized Atrial Tissue Patch Cardiomyoplasty With Omentopexy Improves Cardiac Performance After Myocardial Infarction Ann. Thorac. Surg., October 1, 2011; 92(4): 1435 - 1442. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Doenst Invited Commentary Ann. Thorac. Surg., October 1, 2008; 86(4): 1249 - 1249. [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |